Menu
GeneBe

rs115186224

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2

The NM_000254.3(MTR):c.1076-8C>T variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00378 in 1,611,136 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0039 ( 24 hom. )

Consequence

MTR
NM_000254.3 splice_region, splice_polypyrimidine_tract, intron

Scores

2
Splicing: ADA: 0.001340
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.610
Variant links:
Genes affected
MTR (HGNC:7468): (5-methyltetrahydrofolate-homocysteine methyltransferase) This gene encodes the 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.26).
BP6
Variant 1-236831958-C-T is Benign according to our data. Variant chr1-236831958-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 296558.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-236831958-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00311 (474/152302) while in subpopulation NFE AF= 0.00548 (373/68030). AF 95% confidence interval is 0.00502. There are 2 homozygotes in gnomad4. There are 199 alleles in male gnomad4 subpopulation. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MTRNM_000254.3 linkuse as main transcriptc.1076-8C>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant ENST00000366577.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MTRENST00000366577.10 linkuse as main transcriptc.1076-8C>T splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant 1 NM_000254.3 P1Q99707-1

Frequencies

GnomAD3 genomes
AF:
0.00312
AC:
475
AN:
152184
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00354
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.000829
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00548
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00259
AC:
651
AN:
251180
Hom.:
3
AF XY:
0.00243
AC XY:
330
AN XY:
135754
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00125
Gnomad ASJ exome
AF:
0.000695
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000261
Gnomad FIN exome
AF:
0.000924
Gnomad NFE exome
AF:
0.00480
Gnomad OTH exome
AF:
0.00294
GnomAD4 exome
AF:
0.00385
AC:
5619
AN:
1458834
Hom.:
24
Cov.:
30
AF XY:
0.00377
AC XY:
2733
AN XY:
725896
show subpopulations
Gnomad4 AFR exome
AF:
0.000629
Gnomad4 AMR exome
AF:
0.00136
Gnomad4 ASJ exome
AF:
0.00211
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000302
Gnomad4 FIN exome
AF:
0.00105
Gnomad4 NFE exome
AF:
0.00471
Gnomad4 OTH exome
AF:
0.00272
GnomAD4 genome
AF:
0.00311
AC:
474
AN:
152302
Hom.:
2
Cov.:
33
AF XY:
0.00267
AC XY:
199
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.000650
Gnomad4 AMR
AF:
0.00353
Gnomad4 ASJ
AF:
0.00144
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.000659
Gnomad4 NFE
AF:
0.00548
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00404
Hom.:
2
Bravo
AF:
0.00280
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00545
EpiControl
AF:
0.00379

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2023MTR: BP4, BS2 -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesSep 18, 2023- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 28, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Disorders of Intracellular Cobalamin Metabolism Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Methylcobalamin deficiency type cblG Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.26
Cadd
Benign
14
Dann
Benign
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0013
dbscSNV1_RF
Benign
0.064
SpliceAI score (max)
0.15
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115186224; hg19: chr1-236995258; API